In a head-to-head study that pitted Suflave against Sebela Pharmaceuticals' SUPREP ® Bowel Prep Kit, the majority of patients said that Suflave "tastes like a sports drink," and 79 percent of ...

The Suprep Bowel Prep Kit, for example, requires drinking just two cups of liquid laxative – once in the evening before your procedure, and once the morning of.

The company reported that, in a head-to-head study against its own oral sulfate product, Suprep bowel prep kit, Suflave demonstrated noninferiority with 94% of patients achieving successful bowel ...

“With the FDA approval of Plenvu, physicians can now offer their patients a new preparation option for colonoscopies that features a lower-volume, one-liter PEG bowel preparation,” said Mark ...

1. The researchers featured patients aged 18 years and older who presented for an outpatient colonoscopy at a large medical center in the study. The study's primary outcome was bowel cleansing quality ...

Nancy Brown, 60, described her preparation with Suprep as “very tolerable,” a far cry from her son's experience 12 years ago. The days of drinking a gallon of oily liquid the night before a ...

The Patent at Issue The patent at issue was Braintree’s U.S. 6,946,149, which is listed in the Orange Book for its SUPREP® Bowel Prep Kit for preparing patients for colonoscopies.

Strides Pharma receives FDA OK for 2 generics Strides Pharma has received the FDA's clearance for generic Suprep Bowel Prep Kit Oral Solution and generic Keppra Oral Solution.

By Reuters February 28, 20175:09 AM UTCUpdated ago Feb 28 (Reuters) - Lupin Ltd: * Says Lupin receives FDA approval for generic Suprep bowel prep kit * Says Lupin shall commence promoting the ...

This Hatch-Waxman litigation concerns an Abbreviated New Drug Application (ANDA) filed by Novel Laboratories, Inc. (Novel) for a generic version of the SUPREP® Bowel Prep Kit (SUPREP), a product ...

Aug 23 (Reuters) - Perrigo Company Plc * Perrigo announces tentative FDA approval for generic version of Suprep oral solution and confirms patent challenge for generic version of Mirvaso gel ...